![](/img/cover-not-exists.png)
PCN208 COST-EFFECTIVENESS OF NIVOLUMAB FOR THE ADJUVANT TREATMENT OF PATIENTS WITH MELANOMA WITH INVOLVEMENT OF LYMPH NODES OR METASTATIC DISEASE WHO HAVE UNDERGONE COMPLETE RESECTION: AN ANALYSIS FROM A SWISS HEALTHCARE SYSTEM PERSPECTIVE
Oniangue-Ndza, C., Strittmatter, G., Orsini, I., Teitsson, S., Augusto, M., Amadi, A.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.404
Date:
November, 2019
File:
PDF, 321 KB
2019